In line with this, KD of ADAM9 in HCT116 cells drastically reduced phospho-S6K, a signature mTOR target that facilitates tumor invasion including CRC invasion (32, 33, 34), without affecting total S6K levels (Fig. 4D and S4A). This evidence concerns the gene ADAM9 and neoplasm.